Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 31;14(1):200-209.
doi: 10.1080/19382014.2022.2149206.

Genome-edited zebrafish model of ABCC8 loss-of-function disease

Affiliations

Genome-edited zebrafish model of ABCC8 loss-of-function disease

Jennifer M Ikle et al. Islets. .

Abstract

ATP-sensitive potassium channel (KATP)gain- (GOF) and loss-of-function (LOF) mutations underlie human neonatal diabetes mellitus (NDM) and hyperinsulinism (HI), respectively. While transgenic mice expressing incomplete KATP LOF do reiterate mild hyperinsulinism, KATP knockout animals do not exhibit persistent hyperinsulinism. We have shown that islet excitability and glucose homeostasis are regulated by identical KATP channels in zebrafish. SUR1 truncation mutation (K499X) was introduced into the abcc8 gene to explore the possibility of using zebrafish for modeling human HI. Patch-clamp analysis confirmed the complete absence of channel activity in β-cells from K499X (SUR1-/-) fish. No difference in random blood glucose was detected in heterozygous SUR1+/- fish nor in homozygous SUR1-/- fish, mimicking findings in SUR1 knockout mice. Mutant fish did, however, demonstrate impaired glucose tolerance, similar to partial LOF mouse models. In paralleling features of mammalian diabetes and hyperinsulinism resulting from equivalent LOF mutations, these gene-edited animals provide valid zebrafish models of KATP -dependent pancreatic diseases.

Keywords: KATP; calcium channels; insulin secretion; metabolism; pancreas; zebrafish.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

None
Graphical abstract
(A) Schematic of predicted protein truncation due to mutation in abcc8. (B) Scatter-plot showing no difference between mutant and control animal weight at 8 weeks. (C) Linear graph of fasting blood glucose over time shows no significant differences between mutant and controls. (D) Linear graph of blood glucose over time in response to intraperitoneal GTT shows increased blood glucose of homozygous mutants at 30 minute timepoint but no difference at 0 or 240 minute timepoints.
Figure 1.
Genome-modified zebrafish model of SUR1 LOF (a) Schematic of SUR1 protein structure showing functional domains and indicating location of premature stop mutation (K499X) within TMD1. (b) Body weight in WT (n = 11), heterozygous SUR1 mutants (n = 12) and SUR1 knockout (n = 12) fish at age 8 weeks. Density of β-cell within individual islets is not different between WT (n = 5) and SUR1 mutant (n = 15). (c) Fasting blood glucose over time shows no significant difference between homozygous mutants and controls (n = 11–16 per timepoint). (d) Blood glucose versus time in response to glucose load in SUR1−/−, WT and SUR1+/- fish (n = 8–16 per timepoint).
(A) Electrophysiologic tracing of control and mutant patch clamps with pA on y-axis and time on x-axis; changes in [ATP] (mM) or addition of diazoxide indicated below x-axis. Controls show channel responsivity to increasing glucose concentrations and to addition of diazoxide.
Figure 2.
SUR1 LOF [499X] abolishes KATP channel activity (a) Representative KATP channel activity in inside-out patch clamp recordings from inside-out patch clamp recordings of WT (above) and homozygous SUR1[499X] (SUR1−/−) mutant β-cells (below) in the presence of ATP (μM), or addition of diazoxide (mM), as indicated. Voltage was clamped at −50 mV. (b) KATP channel density in WT and SUR1-/- patches (n = 17,10).
(A) Plot of relative fluorescence (y-axis) over time (x-axis) in relation to changing glucose or potassium concentrations from representative islets. Control islets show no relative fluorescence at 2 mM glucose but increase to 0.1–0.2 in response to changing to 20 mM glucose. Mutant islets show a higher degree of fluorescence at 2 mM glucose than their wildtype counterparts.
Figure 3.
SUR1−/− islets exhibit elevated basal [Ca2+] and reduced responsivity to glucose (a) Representative recordings of intracellular calcium in the presence of 2 mM glucose (2 G) and following switch to 20 mM glucose (20 G) and then 30 mM KCl (30 K), for WT (above, n = 6) and SUR1−/− (below, n = 12). Fluorescence is normalized to maximum fluorescence in 30 K (f = 1), and minimum fluorescence (f = 0) anywhere within the record. Values for each islet are also shown. (b) Average calcium in each condition for WT (N = 8) and SUR1−/− (n = 14). Data in B are analyzed by 1-way ANOVA followed by multiple unpaired t-tests. (*) p < .05, (**) p < .01.

References

    1. Koster JC, Remedi MS, Masia R, Patton B, Tong A, Nichols CG.. Expression of ATP-insensitive KATP channels in pancreatic beta-cells underlies a spectrum of diabetic phenotypes. Diabetes. 2006;55:2957–2964. doi:10.2337/db06-0732. - DOI - PubMed
    1. Shyng S, Nichols CG. Octameric stoichiometry of the KATP channel complex. J Gen Physiol. 1997;110:655–664. doi:10.1085/jgp.110.6.655. - DOI - PMC - PubMed
    1. Martin GM, Yoshioka C, Rex EA, Fay, JF, Xie, Q, Whorton, MR, Chen, JZ, Shyng, SL, et al. Cryo-EM structure of the ATP-sensitive potassium channel illuminates mechanisms of assembly and gating. eLife. 2017;6. - PMC - PubMed
    1. Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol. 1989;54:87–143. doi:10.1016/0079-6107(89)90013-8. - DOI - PubMed
    1. Huopio H, Shyng SL, Otonkoski T, Nichols CG. K(ATP) channels and insulin secretion disorders. Am J Physiol Endocrinol Metab. 2002;283:E207–16. doi:10.1152/ajpendo.00047.2002. - DOI - PubMed

Publication types

LinkOut - more resources